Abstract
Cholecystokinin-tetrapeptide (CCK-4) and placebo were injected to 11 panic disorder patients. CCK-4 induced a panic attack identical to spontaneous panic attacks in all patients; placebo did not induce any attacks. The role of CCK-4 in anxiety disorders is discussed.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anxiety Disorders / diagnosis*
-
Anxiety Disorders / psychology
-
Clinical Trials as Topic
-
Double-Blind Method
-
Fear / drug effects*
-
Female
-
Gastrins*
-
Humans
-
Male
-
Middle Aged
-
Panic / drug effects*
-
Tetragastrin*